Dementia was rare in ancient times … 4 US sites join Parkinson’s disease genetics study… Risvodetinib phase 1 results for Parkinson’s promising … Disparities have a say in stroke recovery … US has higher prescription costs than other nations … Biogen calls it quits for Alzheimer’s drug Aduhelm … StartUp Health debuts Alzheimer’s Moonshot initiative
